The WRITTEN-HEART study (expressive writing for heart healing): rationale and design of a randomized controlled clinical trial of expressive writing in coronary patients referred to residential cardiac rehabilitation

Gian Mauro Manzoni, Gianluca Castelnuovo, Enrico Molinari, Gian Mauro Manzoni, Gianluca Castelnuovo, Enrico Molinari

Abstract

Background: Coronary heart disease (CHD) is typically associated with many cardiovascular risk factors (e.g., elevated blood pressure), low health-related quality of life, depression, anxiety and psychological stress. Expressive writing (EW) has shown beneficial effects on such variables in both people from the community and in patients with a variety of chronic illnesses. However, no study to date has evaluated the physical and psychological effects of the expressive writing procedure on coronary patients referred to cardiac rehabilitation (CR).

Methods: The clinical effectiveness of a 2-week disease-related expressive writing procedure (writing about one's deepest thoughts and feelings regarding the experience with heart disease) compared with the standard writing task (writing about one's deepest thoughts and feelings about the most traumatic or negative event experienced in the life), a neutral writing condition (writing about the facts regarding heart disease and its treatment) and an empty control condition will be evaluated in a randomized controlled clinical trial (RCT) with repeated follow-up measurements at 3, 6 and 12 months after discharge from CR. The primary outcome is health-related quality of life (SF-12). Secondary outcome measures are depression (BDI-II), anxiety (BAI) and post-traumatic growth (PTGI). Furthermore, the study will explore the moderating effects of coping styles, type D personality, perceived emotional support and participants' evaluative ratings of the writing interventions on the main experimental effects in order to identify sub-groups of patients showing different results.

Discussion: The WRITTEN-HEART study aims to explore and expand the frontiers of the expressive writing research enterprise by investigating the feasibility, safety and clinical efficacy of brief and cost-effective expressive writing interventions in patients with CHD referred to CR.

Trial registration: ClinicalTrials.gov NCT01253486.

References

    1. WHO. Fact sheet N°317.
    1. O'Keefe JH, Carter MD, Lavie CJ. Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc. 2009;84(8):741–757. doi: 10.4065/84.8.741.
    1. Lear SA, Ignaszewski A. Cardiac rehabilitation: a comprehensive review. Curr Control Trials Cardiovasc Med. 2001;2(5):221–232. doi: 10.1186/CVM-2-5-221.
    1. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345(12):892–902. doi: 10.1056/NEJMra001529.
    1. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005;45(5):637–651. doi: 10.1016/j.jacc.2004.12.005.
    1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.
    1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99(16):2192–2217.
    1. Dobbels F. Does every cardiologist need a psychologist? Eur Heart J. 2007;28(24):2964–2966. doi: 10.1093/eurheartj/ehm522.
    1. Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J. 2007;28(24):2972–2984. doi: 10.1093/eurheartj/ehm504.
    1. Pennebaker JW, Beall SK. Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol. 1986;95(3):274–281.
    1. Smyth JM, Pennebaker JW. Exploring the boundary conditions of expressive writing: In search of the right recipe. Br J Health Psychol. 2008;13(Pt 1):1–7.
    1. Gidron Y, Peri T, Connolly JF, Shalev AY. Written Disclosure in Posttraumatic Stress Disorder: Is It Benefical for the Patient. The Journal of Nervous and Mental Disease. 1996;184(8):505–506. doi: 10.1097/00005053-199608000-00009.
    1. Sloan DM, Marx BP. Taking Pen to Hand: Evaluating Theories Underlying the Written Disclosure Paradigm. Clinical Psychology: Science and Practice. 2004;11(2):121–137. doi: 10.1093/clipsy.bph062.
    1. Frisina PG, Borod JC, Lepore SJ. A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. J Nerv Ment Dis. 2004;192(9):629–634. doi: 10.1097/01.nmd.0000138317.30764.63.
    1. Stanton AL, Danoff-Burg S, Sworowski LA, Collins CA, Branstetter AD, Rodriguez-Hanley A, Kirk SB, Austenfeld JL. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J Clin Oncol. 2002;20(20):4160–4168. doi: 10.1200/JCO.2002.08.521.
    1. Walker BL, Nail LM, Croyle RT. Does emotional expression make a difference in reactions to breast cancer? Oncol Nurs Forum. 1999;26(6):1025–1032.
    1. Low CA, Stanton AL, Danoff-Burg S. Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects. Health Psychol. 2006;25(2):181–189.
    1. Low CA, Stanton AL, Bower JE, Gyllenhammer L. A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer. Health Psychol. 2010;29(4):460–466.
    1. Kelley JE, Lumley MA, Leisen JC. Health effects of emotional disclosure in rheumatoid arthritis patients. Health Psychol. 1997;16(4):331–340.
    1. Gillis ME, Lumley MA, Mosley-Williams A, Leisen JC, Roehrs T. The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial. Ann Behav Med. 2006;32(2):135–146. doi: 10.1207/s15324796abm3202_11.
    1. Mann T. Effects of future writing and optimism on health behaviors in HIV-infected women. Ann Behav Med. 2001;23(1):26–33. doi: 10.1207/S15324796ABM2301_5.
    1. Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med. 2004;66(2):272–275. doi: 10.1097/01.psy.0000116782.49850.d3.
    1. de Moor C, Sterner J, Hall M, Warneke C, Gilani Z, Amato R, Cohen L. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychol. 2002;21(6):615–619.
    1. Rosenberg HJ, Rosenberg SD, Ernstoff MS, Wolford GL, Amdur RJ, Elshamy MR, Bauer-Wu SM, Ahles TA, Pennebaker JW. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med. 2002;32(1):37–53. doi: 10.2190/AGPF-VB1G-U82E-AE8C.
    1. Norman SA, Lumley MA, Dooley JA, Diamond MP. For whom does it work? Moderators of the effects of written emotional disclosure in a randomized trial among women with chronic pelvic pain. Psychosom Med. 2004;66(2):174–183. doi: 10.1097/01.psy.0000116979.77753.74.
    1. McGuire KM, Greenberg MA, Gevirtz R. Autonomic effects of expressive writing in individuals with elevated blood pressure. J Health Psychol. 2005;10(2):197–209. doi: 10.1177/1359105305049767.
    1. Solano L, Donati V, Pecci F, Persichetti S, Colaci A. Postoperative course after papilloma resection: effects of written disclosure of the experience in subjects with different alexithymia levels. Psychosom Med. 2003;65(3):477–484. doi: 10.1097/01.PSY.0000035781.74170.F1.
    1. Solano L, Pepe L, Donati V, Persichetti S, Laudani G, Colaci A. Differential health effects of written processing of the experience of a surgical operation in high- and low-risk conditions. J Clin Psychol. 2007;63(4):357–369. doi: 10.1002/jclp.20355.
    1. Ullrich PA, Lutgendorf SL. Journaling about stressful events: Effects of cognitive processing and emotional expression. Annals of Behavioral Medicine. 2002;24(244-250)
    1. Affleck G, Tennen H, Croog S, Levine S. Causal attribution, perceived benefits, and morbidity after a heart attack: an 8-year study. J Consult Clin Psychol. 1987;55(1):29–35.
    1. Davis CG, Nolen-Hoeksema S, Larson J. Making sense of loss and benefiting from the experience: two construals of meaning. J Pers Soc Psychol. 1998;75(2):561–574.
    1. Mendola R, Tennen H, Affleck G, McCann L, Fitzgerald T. Appraisal and adaptation among women with impaired fertility. Cognitive Therapy and Research. 1990;14(1):79–93. doi: 10.1007/BF01173526.
    1. Lumley MA, Tojek TM, Macklem DJ. In: The Writing Cure: How Expressive Writing Promotes Health and Emotional Well-Being. Lepore SJ, Smyth JM, editor. Washington DC: American Psychological Association; 2002. The effects of written emotional disclosure among repressive and alexithymic people; pp. 75–95.
    1. Stanton AL, Danoff-Burg S, Cameron CL, Bishop M, Collins CA, Kirk SB, Sworowski LA, Twillman R. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol. 2000;68(5):875–882.
    1. Stanton AL, Kirk SB, Cameron CL, Danoff-Burg S. Coping through emotional approach: scale construction and validation. J Pers Soc Psychol. 2000;78(6):1150–1169.
    1. Zakowski SG, Ramati A, Morton C, Johnson P, Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Health Psychol. 2004;23(6):555–563.
    1. Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006;132(6):823–865.
    1. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.) Hillsdale, N.Y.: Lawrence Earlbaum Associates; 1998.
    1. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care. 1996;34(3):220–233. doi: 10.1097/00005650-199603000-00003.
    1. Apolone G, Mosconi P, Quattrociocchi L, Gianicolo EAL, Groth N, Ware JE. QUESTIONARIO SULLO STATO DI SALUTE SF-12 Versione italiana. Milano: Istituto di Ricerche Farmacologiche Mario Negri; 2005.
    1. Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. Journal of Traumatic Stress. 1996;9(3):455–471. doi: 10.1002/jts.2490090305.
    1. Cann A, Calhoun LG, Tedeschi RG, Taku K, Vishnevsky T, Triplett KN, Danhauer SC. A short form of the Posttraumatic Growth Inventory. Anxiety Stress Coping. 2009. pp. 1–11.
    1. Prati G, Pietrantoni L. Crescita post-traumatica: un'opportunità dopo il trauma? Psicoterapia Cognitiva e Comportamentale. 2006;12(6):133–144.
    1. Stanton AL, Danoff-Burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology. 2002;11(2):93–102. doi: 10.1002/pon.574.
    1. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67(1):89–97. doi: 10.1097/01.psy.0000149256.81953.49.
    1. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92–100. doi: 10.1207/s15327558ijbm0401_6.
    1. Conti L. Repertorio delle Scale di Valutazione in Psichiatria. Firenze: S.E.E. Società Editrice Europea di Nicodemo Maggiulli & C. snc; 1999.
    1. Kwok OM, Underhill AT, Berry JW, Luo W, Elliott TR, Yoon M. Analyzing Longitudinal Data with Multilevel Models: An Example with Individuals Living with Lower Extremity Intra-articular Fractures. Rehabil Psychol. 2008;53(3):370–386.
    1. Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press; 2003.
    1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622–629.
    1. Oldridge NB. Outcome assessment in cardiac rehabilitation. Health-related quality of life and economic evaluation. J Cardiopulm Rehabil. 1997;17(3):179–194. doi: 10.1097/00008483-199705000-00005.
    1. Smyth JM, Nazarian D, Arigo D. In: Emotion Regulation. Nyklíček I, Vingerhoets A, Zeelenberg M, editor. Springer; 2008. Expressive Writing in the Clinical Context.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir